Cardinal Health Extends CVS Distribution Deal to 2032, Reaffirms FY27 Guidance
CAH sits 48% above its 52-week low of $150.775.
Summary
Cardinal Health entered a binding LOI to extend its CVS Health distribution agreement through June 2032 and reaffirmed FY27 EPS guidance of $12.40–$12.60.
Key Events · M&A and Partnerships · CAH
-
CVS Distribution Extension
A binding letter of intent extends existing pharmaceutical distribution agreements with CVS Health through June 30, 2032, continuing the current scope of services.
-
FY27 Guidance Reaffirmed
The company reaffirmed FY2027 non-GAAP EPS guidance of $12.40 to $12.60, representing 13% to 15% growth, and long-term non-GAAP EPS growth of 12% to 14%.
-
Next Update
Further updates may be provided during the first quarter earnings call on November 5, 2026.
Analysis · CAH · Trade & Services
Securing a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 2032 removes a major contract-renewal overhang for one of Cardinal Health's largest customers and locks in the current scope of distribution services for another six years. The company also reaffirmed its FY2027 non-GAAP EPS guidance of $12.40–$12.60 and long-term growth of 12–14%, signaling confidence in the underlying business. The deal is a significant positive for revenue visibility, though the LOI is not yet a definitive agreement.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 29.2% of the 1503 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.39%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CAH was trading at $222.50 on NYSE in the Trade & Services sector, with a market capitalization of approximately $51.5B. The 52-week trading range was $150.78 to $258.30. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.